Descripción
Antithrombotic / Antiplatelet
Formula:
Each tablets contain:
- Ticagrelor 90mg
Indications:
TICAZAN is a platelet inhibitor indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI). For at least the first 12 months following ACS. TICAZAN also reduces the rate of stent thrombosis in patients who have been stented for treatment of ACS.
Dosage:
Initiate treatment with 180mg oral loading dose following an ACS event. Continue treatment with 90mg twice daily during the first year after an ACS event. After one year, administer 60mg twice daily.
Presentation:
Box with 30 coated tablets.
Valoraciones
No hay valoraciones aún.